Genmab A/S (GMAB)
38.48
+3.73
(+10.73%)
USD |
NASDAQ |
Oct 05, 16:00
38.66
+0.18
(+0.47%)
After-Hours: 20:00
Genmab Price : 38.48 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 35.09 | 40.17 | 35.02 | 38.48 | 12.40M |
| Oct 02, 2026 | 34.39 | 35.02 | 33.72 | 34.75 | 5.436M |
| Oct 01, 2026 | 35.25 | 35.80 | 34.52 | 34.55 | 6.377M |
| Sep 30, 2026 | 35.72 | 35.90 | 35.37 | 35.68 | 5.155M |
| Sep 29, 2026 | 34.94 | 35.64 | 34.89 | 35.57 | 3.828M |
| Sep 28, 2026 | 34.76 | 35.70 | 34.63 | 35.36 | 2.795M |
| Sep 25, 2026 | 34.95 | 35.47 | 34.70 | 35.32 | 3.583M |
| Sep 24, 2026 | 34.69 | 35.03 | 34.36 | 34.83 | 2.515M |
| Sep 23, 2026 | 35.39 | 35.66 | 34.60 | 34.75 | 2.510M |
| Sep 22, 2026 | 34.46 | 35.30 | 34.37 | 35.22 | 2.298M |
| Sep 21, 2026 | 34.70 | 34.86 | 34.36 | 34.69 | 1.577M |
| Sep 18, 2026 | 34.92 | 35.15 | 34.72 | 34.74 | 2.712M |
| Sep 17, 2026 | 34.28 | 34.77 | 34.22 | 34.54 | 2.703M |
| Sep 16, 2026 | 34.36 | 34.63 | 34.05 | 34.40 | 2.886M |
| Sep 15, 2026 | 32.34 | 34.18 | 32.34 | 34.15 | 3.085M |
| Sep 14, 2026 | 32.79 | 32.96 | 32.52 | 32.65 | 1.412M |
| Sep 11, 2026 | 32.45 | 32.70 | 32.27 | 32.47 | 1.394M |
| Sep 10, 2026 | 32.46 | 32.68 | 32.21 | 32.23 | 1.016M |
| Sep 09, 2026 | 33.47 | 33.75 | 32.98 | 33.04 | 2.126M |
| Sep 08, 2026 | 33.71 | 33.84 | 33.36 | 33.53 | 1.551M |
| Sep 04, 2026 | 33.96 | 34.19 | 33.54 | 33.60 | 1.003M |
| Sep 03, 2026 | 34.63 | 34.66 | 34.08 | 34.41 | 890948.0 |
| Sep 02, 2026 | 34.04 | 34.50 | 33.74 | 34.22 | 2.079M |
| Sep 01, 2026 | 33.33 | 33.67 | 33.15 | 33.29 | 1.563M |
| Aug 31, 2026 | 32.76 | 33.26 | 32.54 | 33.16 | 1.733M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 228.03 |
| Zealand Pharma A/S | 40.00 |
| AbbVie, Inc. | 265.76 |
| Bavarian Nordic A/S | 11.08 |
| Evaxion AS | 3.15 |
Price Related Metrics
| PE Ratio | 30.47 |
| PS Ratio | 5.941 |
| Price to Book Value | 3.856 |
| Price to Free Cash Flow | 28.22 |
| Earnings Yield | 3.28% |
| Market Cap | 22.97B |
| Operating PE Ratio | 18.41 |
| Normalized PE Ratio | 24.97 |